ABCL-102 A SEER-Medicare Analysis of the Cost of Disease Progression After Frontline R-CHOP in Diffuse Large B-Cell Lymphoma

Autor:	Burke, John M. 1, Wang, Rongrong 2, Hossain, Farah 2, Li, Jia 2, Masaquel, Anthony 2, Zhou, Summera Qiheng 3, Matasar, Matthew 4
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S360-S360
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect